Drawing for PRE

USPTO serial 99409027

PRE

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
PAQUIN, SAMUEL ROBERT
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with PRE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $896*

Plus Government fees of $500

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew T. Pettit

Andrew T. Pettit Ashurst Perkins Coie US LLPP.O. Box 2608Seattle, WA 98111United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data using artificial intelligence in the health, medical, scientific and pharmaceutical fields; Downloadable software for data analytics using artificial intelligence in the fields of drug discovery, personalized medicine and patient care pathways; Downloadable computer software using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; Downloadable software for patient case management using artificial intelligence for viewing and sharing patient health information, performing healthcare data analytics, generating patient insights, and managing patient care; Downloadable application programming interface (API) software; Downloadable computer software for use as an application programming interface (API); downloadable software for identity and authorization management in the health, medical, scientific and pharmaceutical fieldsACTIVE—
038Telecommunications access services; telecommunications platform related to health; Providing access to databases; providing access to databases featuring patient health data; providing access to databases featuring medical research data; providing access to databases featuring clinical trial data; providing access to databases featuring health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data and demographic dataACTIVE—
042Providing data analytics and machine learning research services, namely analyzing and organizing clinical, laboratory and genomic data, data mining; scientific research and machine software and artificial intelligence programming and technology consulting in the fields of drug development, personalized medicine and patient care pathways; artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; software as a service (SAAS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; application service provider featuring application programming interface (API) software; software as a service (SAAS) services featuring software for identity and authorization management in the health, medical, scientific and pharmaceutical fields; providing temporary use of on-line non-downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathwaysACTIVE—
044Healthcare services, namely, medical counseling services and treatment monitoring using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultations rendered in virtual environments; Provision of health care and medical services by health care professionals via the Internet or telecommunication networksACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (EISU): The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.

DateCodeEventWhat it means
Oct 7, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 7, 2026ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Oct 7, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 10, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 7, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 10, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 10, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 13, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 12, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 12, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 12, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 10, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2025DOCKASSIGNED TO EXAMINER—
Dec 10, 2025MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Dec 10, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 23, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 23, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance